Form 4: Apogee Enterprises Director Elizabeth Murphy Lilly Receives Deferred Restricted Stock Units

Apogee Enterprises, Inc. Director Elizabeth Murphy Lilly has been granted 2,954 deferred restricted stock units under the company's 2019 Non-Employee Director Stock Plan, aligning her interests with shareholders.

Summary

• Elizabeth Murphy Lilly, a Director of Apogee Enterprises, Inc. (APOG), acquired 2,954 Deferred Restricted Stock Units (RSUs).
• The transaction occurred on June 25, 2025.
• These RSUs were allocated under the 2019 Non-Employee Director Stock Plan.
• Each RSU will be settled on a 1-for-1 basis into shares of Apogee Enterprises common stock.
• Settlement will occur following the director's termination from the Board or upon other events specified in the Plan, based on the reporting person's election.
• Following this transaction, Ms. Lilly beneficially owns a total of 6,733 deferred restricted stock units.
• This total includes additional units acquired through a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates a director's continued alignment with shareholder interests through equity compensation, a standard and generally well-regarded practice.

Positives

• The acquisition of deferred restricted stock units by a director aligns their long-term interests with those of the shareholders.
• The use of a formal stock plan (2019 Non-Employee Director Stock Plan) indicates a structured approach to director compensation.
• The dividend equivalent reinvestment feature allows for compounding of equity holdings, further strengthening alignment.

Negatives

• No immediate cash proceeds for the director from this specific grant, as the units are deferred and settled upon future events.

Risks

• No specific companyor industry-related risks are detailed in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

The deferred restricted stock units are set to be settled in shares of common stock following the director's termination from the Board or upon the occurrence of other specified events in the 2019 Non-Employee Director Stock Plan, indicating a future conversion of these units into equity.

Industry Context

The granting of deferred restricted stock units to non-employee directors is a common practice across various industries, particularly in publicly traded companies, to incentivize long-term commitment and align director interests with shareholder value creation. This aligns with standard corporate governance practices for director compensation.

Corporate Governance

Related Party Transactions

• The grant of deferred restricted stock units to Elizabeth Murphy Lilly, a director, constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: Positive impact as the director's interests are further aligned with long-term shareholder value through equity ownership.

Next Steps

• Settlement of the 2,954 deferred restricted stock units into common stock shares upon the director's termination from the Board or other events specified in the 2019 Non-Employee Director Stock Plan.

Key Dates

Keywords

Apogee Enterprises, APOG, SEC Form 4, Insider Transaction, Restricted Stock Units, RSUs, Director Compensation, Equity Grant, Stock Plan, Corporate Governance